Completed
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
What is being collected
Data Collection
Who is being recruted
Immune System Diseases
+ Immunologic Deficiency Syndromes
+ Neoplasms
How is the trial designed
Observational
Study Start: April 1977
Summary
Principal SponsorNational Cancer Institute (NCI)
Last updated: March 5, 2008
Sourced from a government-validated database.Claim as a partner
Study start date: April 1, 1977
Actual date on which the first participant was enrolled.The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Principal SponsorNational Cancer Institute (NCI)
Last updated: March 5, 2008
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Immune System DiseasesImmunologic Deficiency SyndromesNeoplasms
Criteria
Patients will be studied if a disorder of the immune system is suspected.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Cancer Institute (NCI)
Bethesda, United StatesOpen National Cancer Institute (NCI) in Google MapsCompletedOne Study Center